Back to top

Tale of the Tape

Zacks Equity Research

Can OvaScience (OVAS) Keep the Earnings Streak Alive This Quarter?
November 30, 2016

OVAS

Trades from $3

Looking for a stock that might be in a good position to beat earnings at its next report? Consider OvaScience, Inc. (OVAS - Free Report) , a firm in the Medical - Biomedical and Genetics industry, which could be a great candidate for another beat.

This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, OVAS has beaten estimates by at least 10% in both cases, suggesting it has a nice short-term history of crushing expectations.

Earnings in Focus

Two quarters ago, OVAS expected to post a loss of 82 cents per share, while it actually produced a loss of 62 cents per share, a beat of 24.4%. Meanwhile, for the most recent quarter, the company looked to deliver a loss of 60 cents per share, when it actually reported loss of 54 cents per share instead, representing a 10% positive surprise.

OVASCIENCE Price and EPS Surprise

 

OVASCIENCE Price and EPS Surprise | OVASCIENCE Quote

Thanks in part to this history, recent estimates have been moving higher for OvaScience. In fact, the Earnings ESP for OVAS is positive, which is a great sign of a coming beat.

After all, the Zacks Earnings ESP compares the most accurate estimate to the broad consensus, looking to find stocks that have seen big revisions as of late, suggesting that analysts have recently become more bullish on the company’s earnings prospects. This is the case for OVAS, as the firm currently has a Zacks Earnings ESP of 3.45%, so another beat could be around the corner.

This is particularly true when you consider that OVAS has a great Zacks Rank #2 (Buy) which can be a harbinger of outperformance and a signal for a strong earnings profile. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

When you add this solid Zacks Rank to a positive Earnings ESP, a positive earnings surprise happens nearly 70% of the time, so it seems pretty likely that OVAS could see another beat at its next report, especially if recent trends are any guide.

Zacks' Top Investment Ideas for Long-Term Profit

How would you like to see our best recommendations to help you find today’s most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>

In-Depth Zacks Research for the Tickers Above

OVASCIENCE (OVAS) - FREE report >>